1-3
2026
影响因子区间
—
平台估算
0%
2025
中国作者发文占比
1969 USD
收费
期刊简介:The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of stem cell research, therapy, ethics, commercialization, and policy. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
【译文】该期刊的目标是发表与干细胞研究、治疗、伦理、商业化和政策相关的尖端综述。我们旨在提供来自每个相关领域的顶尖专家的深刻、有洞察力和平衡的贡献,这些贡献将对广泛的读者群,包括临床医生、基础科学家和转化研究人员产生直接的兴趣。我们通过任命主要权威人士担任学科关键领域的部门编辑来实现这一目标。部门编辑选择由领先专家进行综述的主题,强调最近的发展,并以清晰易读的格式突出过去一年在其主题上发表的重要论文。我们还提供来自该领域知名人士的评论,以及由来自世界各地的多样化成员组成的编辑委员会建议其国家/地区特别感兴趣的主题,并确保主题是当前的,包括新兴研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |